News|Articles|August 14, 2009

Uncovering the root cause of contamination and leveraging the collaborative learning loop of QbD -Aegis Whitepaper

External Link - article-619190.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

CPHI Milan Puts Sustainability to Work, Part 2

BySilvia Forroova

August 14th 2026

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

ByZachary Zubulake

August 14th 2026

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

ByLee Karras,Zachary Zubulake

August 14th 2026

Europe Map with virtual gavel and sound block and AI word. Concept of the EU recently adopted the AI Act, ushering in new restrictions on Artificial Intelligence use cases and mandating transparency | Image Credit: ©tanaonte -stock.adobe.com

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

ByBrian Drapeau

August 13th 2026

CPHI Milan Puts Sustainability to Work, Part 1

BySilvia Forroova

August 13th 2026

Uncovering the root cause of contamination and leveraging the collaborative learning loop of QbD -Aegis Whitepaper

Related Content

CPHI Milan Puts Sustainability to Work, Part 2

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

CPHI Milan Puts Sustainability to Work, Part 1

Trending on Pharmaceutical Technology

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line